Need help? Our team of experienced experts is here for you with full support.
AKA-174
Tirzepatide
Cat. No.
AKA-174
CAS No.
2023788-19-2
MF
C225H348N48O68
MW
4813.53
Tirzepatide is a glucose-dependent insulin nutritive polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor dual agonist.
Advanced Equipments & Extensive Production Expertise
Commercial Manufacturing
Stable Quality
Customization Supporting
Technical Data
Description
Storage and Shipping
References
Product Name
Tirzepatide
CAS No.
2023788-19-2
MF
C225H348N48O68
MW
4813.53
Specification
98%
Research Area
GIP/GLP-1 receptors Agonist,obesity and type 2 diabetes
Description
Tirzepatide is a glucose-dependent insulin nutritive polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor dual agonist. Packing: 10mg, 20mg, 50mg, 100mg, 500mg, 1g, 5g, 10g, 1kg Availability: Under Development (current pilot scale, production validation in 3-4 month, DMF filing in 12 month)
Documents
Certificate of Analysis (COA), API specification, Safety Data Sheet (SDS/MSDS), evidence of GMP compliance, Stability data / Stability summary, etc.
Storage and Shipping
Store in a cool & dry place, keep away from strong light and heat.
References
[1]. Fontanella RA, et al. Tirzepatide prevents neurodegeneration through multiple molecular pathways. Journal of Translational Medicine. 2024 Jan 29;22(1):114.
Disclaimer
This product is intended solely for scientific research or regulatory filing purposes. We do not provide products or services to individuals, please strictly comply with all applicable laws, regulations, and the committed use. Use for any other purpose is strictly prohibited.
Related Products
* Some statements have not been evaluated by national authorities. * Some products are not intended to diagnose, treat, cure, or prevent any disease. * For literature supporting, please contact us directly.